1.
Ann Acad Med Singap
; 51(4): 236-240, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35506407
RESUMO
The prevalence of end-stage kidney disease (ESKD) in Singapore remains high and continues to rise. We continue to face major challenges in containing the rising incidence of ESKD and providing sustainable kidney replacement therapy. Our cost projections provide an insight into the present and future, urging a call to action to augment existing initiatives to address the emergent issues.